AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

Symbol
Price
Change %
Market Cap
Volume
MRNA $33.32 -1.44% $14.18B 6,295,489
PACB $1.64 -6.81% $522.65M 7,127,933
BNTX $105.14 +0.05% $25.26B 487,832
FLGT $22.68 -0.52% $697.89M 192,349
CRSP $69.15 +1.05% $6.22B 2,004,330
ILMN $95.46 -0.46% $14.74B 1,113,116
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.